RAPT
RAPT Therapeutics, Inc. (RAPT
NASDAQ · Healthcare · Biotechnology · US
$58.01
+0.00%Latest reported
- Last report date
- Mar 5, 2026
- EPS actual
- -$9.12
- EPS estimate
- -$0.82
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -228.6%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 5, 2026 | -$0.82 | -$9.12 | Miss -1008.24% | — |
| Nov 6, 2025 | -$0.88 | -$0.65 | Beat 26.14% | — |
| Aug 7, 2025 | -$0.61 | -$0.65 | Miss -6.56% | — |
| May 8, 2025 | -$2.48 | -$0.64 | Beat 74.19% | — |
| Mar 6, 2025 | -$0.45 | -$1.14 | Miss -153.33% | — |
| Aug 8, 2024 | -$0.74 | -$0.71 | Beat 4.05% | — |
| May 9, 2024 | -$0.78 | -$0.79 | Miss -1.28% | — |
| Mar 7, 2024 | -$0.85 | -$0.80 | Beat 5.88% | $5.3M |
| Nov 13, 2023 | -$0.75 | -$0.82 | Miss -9.33% | — |
| Aug 11, 2023 | -$0.80 | -$0.66 | Beat 17.50% | — |
| May 11, 2023 | -$0.64 | -$0.76 | Miss -18.75% | — |
| Mar 14, 2023 | -$0.67 | -$0.64 | Beat 4.48% | $641.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 6, 2026